David Safronetz
Overview
Explore the profile of David Safronetz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
3484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prevost J, Tailor N, Leung A, Warner B, Safronetz D
Emerg Infect Dis
. 2025 Feb;
31(2):385-388.
PMID: 39983702
We inoculated clinical materials into deer mice to attempt isolation of Sin Nombre virus. We did not observe productive infection in the natural rodent reservoir. Genomic comparisons between rodent reservoirs...
2.
Tamming L, Duque D, Tran A, Lansdell C, Frahm G, Wu J, et al.
Mol Ther Methods Clin Dev
. 2025 Jan;
33(1):101388.
PMID: 39759470
[This corrects the article DOI: 10.1016/j.omtm.2024.101325.].
3.
Warner B, Safronetz D, Stein D
Virol J
. 2024 Dec;
21(1):320.
PMID: 39702419
Lassa virus, the cause of deadly Lassa fever, is endemic in West Africa, where thousands of cases occur on an annual basis. Nigeria continues to report increasingly severe outbreaks of...
4.
Zhang W, Sloan A, Prevost J, Tamming L, Raman S, Pfeifle A, et al.
Emerg Microbes Infect
. 2024 Nov;
13(1):2427792.
PMID: 39508450
The nucleoprotein (NP) of type A influenza virus (IAV) is highly conserved across all virus strains, making it an attractive candidate antigen for universal vaccines. While various studies have explored...
5.
Tamming L, Duque D, Bavananthasivam J, Tran A, Lansdell C, Frahm G, et al.
Mol Ther Methods Clin Dev
. 2024 Sep;
32(3):101325.
PMID: 39309757
The effectiveness of mRNA vaccines largely depends on their lipid nanoparticle (LNP) component. Herein, we investigate the effectiveness of DLin-KC2-DMA (KC2) and SM-102-based LNPs for the intramuscular delivery of a...
6.
Prevost J, Sloan A, Deschambault Y, Tailor N, Tierney K, Azaransky K, et al.
Antiviral Res
. 2024 Sep;
231:105995.
PMID: 39243894
While historically confined to endemic areas, Monkeypox virus (MPXV) infection has increasingly garnered international attention due to sporadic outbreaks in non-endemic countries in the last two decades and its potential...
7.
Bane S, Rosenke K, Feldmann F, Meade-White K, Diawara S, Keita M, et al.
Am J Trop Med Hyg
. 2024 Jun;
111(1):107-112.
PMID: 38834052
Diagnostics for febrile illnesses other than malaria are not readily available in rural sub-Saharan Africa. This study assessed exposure to three mosquito-borne arboviruses-dengue virus (DENV), Zika virus (ZIKV), and chikungunya...
8.
Mejia E, Hizon N, Dueck C, Lidder R, Daigle J, Wonitowy Q, et al.
Sci Total Environ
. 2024 May;
933:173108.
PMID: 38729376
Wastewater-based surveillance (WBS) has shown to be an effective tool in monitoring the spread of SARS-CoV-2 and has helped guide public health actions. Consequently, WBS has expanded to now include...
9.
Warner B, Chan M, Tailor N, Vendramelli R, Audet J, Meilleur C, et al.
Vaccines (Basel)
. 2024 Apr;
12(4).
PMID: 38675786
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged following an outbreak of unexplained viral illness in China in late 2019. Since then, it has spread globally causing a pandemic that...
10.
Salawudeen A, Soule G, Tailor N, Klassen L, Audet J, Sloan A, et al.
Emerg Infect Dis
. 2024 Apr;
30(5):1004-1008.
PMID: 38666640
We evaluated the in vitro effects of lyophilization for 2 vesicular stomatitis virus-based vaccines by using 3 stabilizing formulations and demonstrated protective immunity of lyophilized/reconstituted vaccine in guinea pigs. Lyophilization...